SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
March 20, 2020 07:00 ET
|
Sorrento Therapeutics, Inc.
COVIDTRAPTM is a proprietary ACE2-Fc protein that binds to the S1 domain of the spike protein of the SARS-CoV-2 virus;COVIDTRAP is designed to block the SARS-CoV-2 virus from binding and infecting...
“Are People with Celiac Disease At Greater Risk?’” and other Frequently Asked Questions Regarding COVID-19 and Celiac Disease
March 19, 2020 13:37 ET
|
Beyond Celiac
Philadelphia, PA, March 19, 2020 (GLOBE NEWSWIRE) -- Are people with celiac disease at greater risk for coronavirus? Is hand sanitizer safe for people with celiac disease? These are just two of the...
DATA443 DEPLOYS HIPPA AND PRIVACY ENABLED ARALOC™ FOR ALL COVID-19 RESPONDERS FREE OF CHARGE
March 17, 2020 10:04 ET
|
DATA443 Risk Mitigation Inc.
Open to any organizations of need – worldwideNo limits on usage or geographyProgram runs as long as crisis continues RALEIGH, N.C., March 17, 2020 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation,...
Kiwa Bio-Tech Holds Annual Meeting and Its First Working Session of 2020 By Video Conference
February 18, 2020 06:00 ET
|
Kiwa Bio-Tech Products Group Corp.
Yangling, Shaanxi, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or “the Company”), an emerging agricultural company that develops, manufactures...